Correlation Between Bellerophon Therapeutics and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bellerophon Therapeutics and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellerophon Therapeutics and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellerophon Therapeutics and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Bellerophon Therapeutics and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellerophon Therapeutics with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellerophon Therapeutics and Crinetics Pharmaceuticals.
Diversification Opportunities for Bellerophon Therapeutics and Crinetics Pharmaceuticals
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bellerophon and Crinetics is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Bellerophon Therapeutics and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Bellerophon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellerophon Therapeutics are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Bellerophon Therapeutics i.e., Bellerophon Therapeutics and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bellerophon Therapeutics and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Bellerophon Therapeutics is expected to under-perform the Crinetics Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bellerophon Therapeutics is 1.52 times less risky than Crinetics Pharmaceuticals. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Crinetics Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 2,196 in Crinetics Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 3,524 from holding Crinetics Pharmaceuticals or generate 160.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Bellerophon Therapeutics vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Bellerophon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Crinetics Pharmaceuticals |
Bellerophon Therapeutics and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bellerophon Therapeutics and Crinetics Pharmaceuticals
The main advantage of trading using opposite Bellerophon Therapeutics and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellerophon Therapeutics position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Bellerophon Therapeutics vs. Bio Path Holdings | Bellerophon Therapeutics vs. Capricor Therapeutics | Bellerophon Therapeutics vs. NextCure | Bellerophon Therapeutics vs. Zura Bio Limited |
| Crinetics Pharmaceuticals vs. Cue Biopharma | Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Inhibrx | Crinetics Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |